Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice.

Zingone, Fabiana; Buda, Andrea; Savarino, Edoardo

Zingone, Fabiana; Buda, Andrea; Savarino, Edoardo.

Zingone F; Gastroenterology Unit, Department of Surgical, Oncological and Gastroenterological Sciences, University of Padua, Padua, Italy.
Buda A; Gastroenterology Unit, Department of Oncological Gastrointestinal Surgery, S. Maria del Prato Hospital, Feltre, Italy.
Savarino E; Gastroenterology Unit, Department of Surgical, Oncological and Gastroenterological Sciences, University of Padua, Padua, Italy. Electronic address: edoardo.savarino@unipd.it.

Dig Liver Dis ; 52(11): 1252-1253, 2020 11.

Article in English | MEDLINE | ID: covidwho-846928

Subject(s)

Inflammatory Bowel Diseases; Pneumonia, Viral; Severe acute respiratory syndrome-related coronavirus; Biological Therapy; Humans; Inflammatory Bowel Diseases/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Inflammatory Bowel Diseases / Severe acute respiratory syndrome-related coronavirus Limits: Humans Language: English Journal: Dig Liver Dis Journal subject: Gastroenterology Year: 2020 Document Type: Article Affiliation country: J.dld.2020.09.020

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google